奥氮平、利培酮和舍吲哚治疗精神分裂症的获益-风险评估。 - Suppr

Suppr

超能文献

Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.

作者信息

Kasper S, Hale A, Azorin J M, Möller H J

机构信息

Department of General Psychiatry, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

出版信息

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 2:II1-II14. doi: 10.1007/pl00014165.

DOI:10.1007/pl00014165

PMID:10603070

Abstract

摘要

相似文献

Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 2:II1-II14. doi: 10.1007/pl00014165.

Comparative effectiveness of antipsychotic drugs.

Am J Psychiatry. 2003 Mar;160(3):589-90; author reply 592-3. doi: 10.1176/appi.ajp.160.3.589-a.

[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].

Wien Klin Wochenschr. 2000 Dec 22;112(24):1031-8.

The promise of new drugs for schizophrenia treatment.

Can J Psychiatry. 1997 Apr;42(3):265-73. doi: 10.1177/070674379704200304.

Novel antipsychotics: comparison of weight gain liabilities.

J Clin Psychiatry. 1999 Jun;60(6):358-63.

Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.

Int Clin Psychopharmacol. 1998 Nov;13(6):253-62.

Olanzapine, sertindole and schizophrenia.

Drug Ther Bull. 1997 Nov;35(11):81-3.

Atypical antipsychotics and cognition in schizophrenia.

Arch Gen Psychiatry. 2002 Jun;59(6):571-2; author reply 573-5. doi: 10.1001/archpsyc.59.6.571.

Comparative effectiveness of antipsychotic drugs.

Am J Psychiatry. 2003 Mar;160(3):591-2; author reply 592-3. doi: 10.1176/appi.ajp.160.3.591-a.

Olanzapine and risperidone.

Am J Health Syst Pharm. 2003 Mar 1;60(5):487-8; author reply 488-9. doi: 10.1093/ajhp/60.5.487.

引用本文的文献

Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics.

Eur Arch Psychiatry Clin Neurosci. 2011 Sep;261(6):407-16. doi: 10.1007/s00406-010-0182-2. Epub 2010 Dec 30.

Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics.

Front Behav Neurosci. 2010 Mar 18;4:8. doi: 10.3389/fnbeh.2010.00008. eCollection 2010.

The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.

Eur Arch Psychiatry Clin Neurosci. 2010 Feb;260(1):59-68. doi: 10.1007/s00406-009-0018-0. Epub 2009 May 20.

Sertindole : a review of its use in schizophrenia.

CNS Drugs. 2006;20(3):233-55. doi: 10.2165/00023210-200620030-00005.

[Early recognition and intervention for schizophrenia].

Nervenarzt. 2006 Jan;77(1):23-4, 27-30, 32-4. doi: 10.1007/s00115-005-1925-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 2:II1-II14. doi: 10.1007/pl00014165.

Comparative effectiveness of antipsychotic drugs.

Am J Psychiatry. 2003 Mar;160(3):589-90; author reply 592-3. doi: 10.1176/appi.ajp.160.3.589-a.

[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].

Wien Klin Wochenschr. 2000 Dec 22;112(24):1031-8.

The promise of new drugs for schizophrenia treatment.

Can J Psychiatry. 1997 Apr;42(3):265-73. doi: 10.1177/070674379704200304.

Novel antipsychotics: comparison of weight gain liabilities.

J Clin Psychiatry. 1999 Jun;60(6):358-63.

Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.

Int Clin Psychopharmacol. 1998 Nov;13(6):253-62.

Olanzapine, sertindole and schizophrenia.

Drug Ther Bull. 1997 Nov;35(11):81-3.

Atypical antipsychotics and cognition in schizophrenia.

Arch Gen Psychiatry. 2002 Jun;59(6):571-2; author reply 573-5. doi: 10.1001/archpsyc.59.6.571.

Comparative effectiveness of antipsychotic drugs.

Am J Psychiatry. 2003 Mar;160(3):591-2; author reply 592-3. doi: 10.1176/appi.ajp.160.3.591-a.

Olanzapine and risperidone.

Am J Health Syst Pharm. 2003 Mar 1;60(5):487-8; author reply 488-9. doi: 10.1093/ajhp/60.5.487.

引用本文的文献

Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics.

Eur Arch Psychiatry Clin Neurosci. 2011 Sep;261(6):407-16. doi: 10.1007/s00406-010-0182-2. Epub 2010 Dec 30.

Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics.

Front Behav Neurosci. 2010 Mar 18;4:8. doi: 10.3389/fnbeh.2010.00008. eCollection 2010.

The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.

Eur Arch Psychiatry Clin Neurosci. 2010 Feb;260(1):59-68. doi: 10.1007/s00406-009-0018-0. Epub 2009 May 20.

Sertindole : a review of its use in schizophrenia.

CNS Drugs. 2006;20(3):233-55. doi: 10.2165/00023210-200620030-00005.

[Early recognition and intervention for schizophrenia].

Nervenarzt. 2006 Jan;77(1):23-4, 27-30, 32-4. doi: 10.1007/s00115-005-1925-6.